Apellis Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of APLS for the last quarter is 146.38 M USD, and it's 32.59% higher compared to the previous quarter. The net income of Q4 23 is -88.58 M USD.